Related Experiment Video
Updated: Jan 7, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Remimazolam in pediatric ambulatory anesthesia: a critical review and clinical perspective
Yi Zhang1, Hongchen Liu2, Linyun Wang3
1Department of Anesthesiology, Maternal and Child Health Hospital of Wanzhou District, Chongqing, China.
Insights
Remimazolam shows promise for pediatric anesthesia due to its rapid action and recovery. However, more research, especially in infants and on long-term effects, is needed before widespread use.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
Background:
- Pediatric anesthesia requires agents with rapid onset, precise control, and predictable recovery.
- Remimazolam, an ultrashort-acting benzodiazepine, theoretically fits these requirements due to its unique metabolism.
Purpose of the Study:
- To evaluate the current evidence for remimazolam in pediatric day surgery.
- To identify gaps in knowledge regarding its use in young children and long-term outcomes.
Main Methods:
- Review of existing pediatric studies on remimazolam.
- Analysis of limitations in current evidence, including study size and design.
Main Results:
- Current pediatric evidence for remimazolam is limited, primarily from small observational studies.
- Significant data gaps exist for infants under two years and for long-term neurodevelopmental effects.
Conclusions:
- Remimazolam presents a potential option for pediatric anesthesia.
- Cautious use in selected cases is advised pending robust randomized controlled trials and further safety data.
Abstract:
The management of anesthesia for pediatric day surgery demands rapid onset, precise control, and predictable recovery. Remimazolam, an ultrashort-acting benzodiazepine with esterase-dependent metabolism, theoretically meets these needs. However, current pediatric evidence relies primarily on small observational studies with methodological limitations; data for infants under 2 years and long-term neurodevelopmental outcomes remain virtually absent. We conclude that while remimazolam holds promise, its use must be cautious and restricted to carefully selected scenarios until robust randomized controlled trials become available.
More Related Videos
06:38Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
Published on: June 11, 2017
06:46Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Delivery: Enteral Route